Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Histogen Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 22 | 25 | +3 |
| Shares | 2.84M | 8.31M | +5.47M (+192.6%) |
| Value | $2.15M | $2.76M | +$610.7K (+28.4%) |
New holders (8)
Institutions that held Histogen Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 4,941,178 | $1.64M | 0.04% |
| Renaissance Technologies LLC | 652,680 | $217.0K | 0.00% |
| UBS Group AG | 34,642 | $11.0K | 0.00% |
| Jane Street Group, LLC | 28,837 | $10.0K | 0.00% |
| Synovus Financial Corp | 21,000 | $7.00K | 0.00% |
| Compagnie Lombard Odier SCmA | 300 | $0 | 0.00% |
| Ellevest, Inc. | 15 | $0 | 0.00% |
| Tyler-Stone Wealth Management | 100 | $0 | 0.00% |
Sold out (5)
Institutions that held Histogen Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Meitav Dash Investments Ltd | 124,000 | $94.0K |
| Natixis | 79,800 | $60.0K |
| IPG Investment Advisors LLC | 40,000 | $30.3K |
| Susquehanna International Group, LLP | 11,458 | $9.00K |
| Prentice Wealth Management LLC | 1,000 | $1.00K |